CAXADE
LIVE

Serial Number

79092966

Owner

ASTELLAS PHARMA INC.

Filing Date

Jan 4, 2011

Add to watchlist:

No watchlists yet
View on USPTO

CAXADE Trademark

Serial Number: 79092966 • Registration: 3996009

CAXADE is a trademark filed by ASTELLAS PHARMA INC. on January 4, 2011. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ASTELLAS PHARMA INC. (257 trademarks)

3-11 NIHONBASHI-HONCHO 2-CHOME, CHUO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

January 4, 2011

Registration Date

July 19, 2011

Published for Opposition

May 3, 2011

Cancellation Date

January 4, 2021

Goods & Services

Pharmaceutical preparations for the treatment of diabetes

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 7, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 7, 2021 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Oct 23, 2020 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 15, 2018 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 6, 2018 INTS
INVALIDATION PROCESSED
Nov 6, 2018 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 23, 2018 INTR
CANCELLED SECTION 71
Feb 23, 2018 C71T
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jul 16, 2013 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 13, 2013 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 31, 2013 ADCH
NOTIFICATION PROCESSED BY IB
Oct 17, 2011 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 1, 2011 FICS
FINAL DISPOSITION PROCESSED
Sep 1, 2011 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 18, 2011 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 19, 2011 R.PR
PUBLISHED FOR OPPOSITION
May 3, 2011 PUBO
NOTICE OF PUBLICATION
Apr 13, 2011 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2011 CNSA
ASSIGNED TO EXAMINER
Mar 27, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 3, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2011 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 25, 2011 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 24, 2011 REPR